Kyotorphin;(Synonyms: 京都肽) 纯度: 98.37%
Kytorphin 是一种内源性神经活性二肽,可用于缓解疼痛特性的研究。Kyotrophin 具有抗炎和抗菌活性。脑脊髓液中 Kyotorphin 水平与阿尔茨海默病患者神经退行性变的进展呈负相关。
Kyotorphin Chemical Structure
CAS No. : 70904-56-2
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥1000 | In-stock | |
10 mg | ¥1700 | In-stock | |
25 mg | ¥3800 | In-stock | |
50 mg | ; | 询价 | ; |
100 mg | ; | 询价 | ; |
* Please select Quantity before adding items.
Kyotorphin 相关产品
bull;相关化合物库:
- Bioactive Compound Library Plus
- Anti-Infection Compound Library
- Metabolism/Protease Compound Library
- Human Endogenous Metabolite Compound Library
- Antibacterial Compound Library
- Anti-Alzheimer’s Disease Compound Library
- Neurodegenerative Disease-related Compound Library
- Food-Sourced Compound Library
- Peptide Library
生物活性 |
Kyotorphin is an endogenou neuroactive dipeptide with analgesic properties. Kyotorphin possesses anti-inflammatory and antimicrobial activity. Kyotorphin levels in cerebro-spinal fluid correlate negatively with the progression of neurodegeneration in Alzheimer’s Disease patients[1]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 Target |
|
||||||||||||||||
体外研究 (In Vitro) |
The analgesic effect of kyotorphin is determined by means of the hot-plate test, with an ED50 value of 5.3 μg/animal (15.7 nmole/animal)[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
337.37 |
||||||||||||||||
Formula |
C15H23N5O4 |
||||||||||||||||
CAS 号 |
70904-56-2 |
||||||||||||||||
中文名称 |
京都肽 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
Sealed storage, away from moisture
*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (sealed storage, away from moisture) |
||||||||||||||||
溶解性数据 |
In Vitro:;
DMSO : 125 mg/mL (370.51 mM; Need ultrasonic) H2O : 100 mg/mL (296.41 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|